• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters.

作者信息

Salvagno Gian Luca, Henry Brandon M, Pighi Laura, De Nitto Simone, Gianfilippi Gianluca, Lippi Giuseppe

机构信息

Section of Clinical Biochemistry, University of Verona, Verona, Italy.

Service of Laboratory Medicine, Pederzoli Hospital, Peschiera del Garda, Italy.

出版信息

Clin Chem Lab Med. 2021 Nov 23;60(2):e29-e31. doi: 10.1515/cclm-2021-1184. Print 2022 Jan 27.

DOI:10.1515/cclm-2021-1184
PMID:34816677
Abstract
摘要

相似文献

1
The pronounced decline of anti-SARS-CoV-2 spike trimeric IgG and RBD IgG in baseline seronegative individuals six months after BNT162b2 vaccination is consistent with the need for vaccine boosters.在接种BNT162b2疫苗六个月后，基线血清阴性个体中抗SARS-CoV-2刺突三聚体IgG和RBD IgG显著下降，这与疫苗加强针的需求一致。
Clin Chem Lab Med. 2021 Nov 23;60(2):e29-e31. doi: 10.1515/cclm-2021-1184. Print 2022 Jan 27.
2
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.
3
Effect of BNT162b2 booster dose on anti-SARS-CoV-2 spike trimeric IgG antibodies in seronegative individuals.BNT162b2 加强针接种对血清阴性个体抗 SARS-CoV-2 刺突三聚体 IgG 抗体的影响。
Clin Chem Lab Med. 2022 Mar 18;60(6):930-933. doi: 10.1515/cclm-2022-0212. Print 2022 May 25.
4
The Impact of Time between Booster Doses on Humoral Immune Response in Solid Organ Transplant Recipients Vaccinated with BNT162b2 Vaccines.加强针接种间隔时间对 BNT162b2 疫苗接种的实体器官移植受者体液免疫应答的影响。
Viruses. 2024 May 28;16(6):860. doi: 10.3390/v16060860.
5
Spike Antibody Titers Evaluation after a 2-Dose Regimen of BNT162b2 Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2.在先前感染过SARS-CoV-2的医护人员中，接种两剂BNT162b2疫苗后的刺突抗体滴度评估。
Microbiol Spectr. 2021 Dec 22;9(3):e0103621. doi: 10.1128/Spectrum.01036-21. Epub 2021 Nov 10.
6
B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies.SARS-CoV-2 感染诱导的 B 细胞反应可被 BNT162b2 疫苗增强原发性抗体缺陷。
Cells. 2021 Oct 27;10(11):2915. doi: 10.3390/cells10112915.
7
Differential Dynamics of SARS-CoV-2 Binding and Functional Antibodies upon BNT162b2 Vaccine: A 6-Month Follow-Up.BNT162b2 疫苗接种后 SARS-CoV-2 结合和功能性抗体的差异动力学：6 个月随访。
Viruses. 2022 Feb 2;14(2):312. doi: 10.3390/v14020312.
8
Differences in IgG Antibody Responses following BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines.BNT162b2 和 mRNA-1273 两种 SARS-CoV-2 疫苗接种后的 IgG 抗体反应差异。
Microbiol Spectr. 2021 Dec 22;9(3):e0116221. doi: 10.1128/Spectrum.01162-21. Epub 2021 Nov 10.
9
SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best.SARS-CoV-2 疫苗在抗体缺陷患者中引发非典型免疫反应：各显神通。
J Clin Immunol. 2021 Nov;41(8):1709-1722. doi: 10.1007/s10875-021-01133-0. Epub 2021 Oct 20.
10
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.接种 BNT162b2 mRNA 疫苗 6 个月后对 SARS-CoV-2 特异性记忆 B 细胞的证据。
Front Immunol. 2021 Sep 28;12:740708. doi: 10.3389/fimmu.2021.740708. eCollection 2021.

引用本文的文献

1
Evaluation of the performance of a lateral flow device for quantitative detection of anti-SARS-CoV-2 IgG.用于定量检测抗SARS-CoV-2 IgG的侧向流动装置性能评估。
Clin Immunol Commun. 2022 Dec;2:130-135. doi: 10.1016/j.clicom.2022.09.001. Epub 2022 Sep 14.
2
Kinetics of SARS-CoV-2 Serum Antibodies Through the Alpha, Delta, and Omicron Surges Among Vaccinated Health Care Workers at a Boston Hospital.波士顿一家医院接种疫苗的医护人员中，SARS-CoV-2血清抗体在阿尔法、德尔塔和奥密克戎毒株激增期间的动力学。
Open Forum Infect Dis. 2023 May 17;10(7):ofad266. doi: 10.1093/ofid/ofad266. eCollection 2023 Jul.
3
Comparative longitudinal variation of total IgG and IgA anti-SARS-CoV-2 antibodies in recipients of BNT162b2 vaccination.
BNT162b2疫苗接种者中抗SARS-CoV-2总IgG和IgA抗体的比较纵向变化
Adv Lab Med. 2021 Dec 20;3(1):39-50. doi: 10.1515/almed-2021-0086. eCollection 2022 Mar.
4
Assessment of immunoglobin G (spike and nucleocapsid protein) response to COVID-19 vaccination in Palestine.巴勒斯坦人群中新冠病毒疫苗接种后免疫球蛋白G（刺突蛋白和核衣壳蛋白）反应的评估。
Clin Epidemiol Glob Health. 2023 Jul-Aug;22:101330. doi: 10.1016/j.cegh.2023.101330. Epub 2023 Jun 3.
5
Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers.BNT162b2加强剂量对一大群意大利医护人员中SARS-CoV-2抗三聚体刺突抗体动力学的影响
Vaccines (Basel). 2023 Feb 17;11(2):463. doi: 10.3390/vaccines11020463.
6
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.第三剂 COVID-19 mRNA 疫苗接种后针对奥密克戎变异株的持续 T 细胞介导的免疫应答。
Front Immunol. 2023 Jan 23;14:1099246. doi: 10.3389/fimmu.2023.1099246. eCollection 2023.
7
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants.刺突蛋白 RBD 中隐蔽表位的分子工程提高了 SARS-CoV-2 变体的制造可行性和中和广谱性。
Vaccine. 2023 Jan 27;41(5):1108-1118. doi: 10.1016/j.vaccine.2022.12.062. Epub 2022 Dec 29.
8
An Evaluation of Serological Tests to Determine Postvaccinal Immunity to SARS-CoV-2 by mRNA Vaccines.通过mRNA疫苗评估血清学检测以确定对SARS-CoV-2的疫苗接种后免疫力
J Clin Med. 2022 Dec 19;11(24):7534. doi: 10.3390/jcm11247534.
9
Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers.接种 BNT162b2 mRNA 疫苗后，对希腊医护人员 IgG 和 IgA 抗刺突和抗受体结合域的长期反应进行联合监测。
PLoS One. 2022 Nov 21;17(11):e0277827. doi: 10.1371/journal.pone.0277827. eCollection 2022.
10
Systemic and Mucosal Humoral Immune Response Induced by Three Doses of the BNT162b2 SARS-CoV-2 mRNA Vaccines.三剂BNT162b2 SARS-CoV-2 mRNA疫苗诱导的全身和黏膜体液免疫反应
Vaccines (Basel). 2022 Oct 1;10(10):1649. doi: 10.3390/vaccines10101649.